MUVON Secures Innosuisse Grant as Implementation Partner

MUVON is excited to announce that our consortium has been awarded an Innosuisse grant, marking a major milestone on our journey to scale out manufacturing and accelerate the path toward a commercial product.

Having achieved our positive Phase 2 clinical milestone, we are now concentrating our development efforts on enhanced standardization of the manufacturing process to ensure clinical and commercial scalability and robustness, which is the focus of this Innosuisse grant.

As the implementation partner, MUVON will work hand in hand with the outstanding team at ZHAW Zurich University of Applied Sciences, led by Prof. Dr. Lukas Neutsch , to advance control and automation in our production processes and ensure that our regenerative therapies reach millions of patients sooner.

This partnership represents another significant step in our mission to transform patient care through innovation, collaboration, and world-class science.